Shi Feng
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 10
- Chronic Kidney Disease and Diabetes 8
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 5
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Organ Transplantation Techniques and Outcomes 4
- Cited by
- NephrologyHepatologyTransplantation
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Shi Feng
61 papers receiving 760 citations
Peers
Comparison fields: 5 of 98
- Nephrology 136
- Hepatology 84
- Transplantation 27
- Cancer Research 112
- Clinical Biochemistry 33
Countries citing papers authored by Shi Feng
This map shows the geographic impact of Shi Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Feng more than expected).
Fields of papers citing papers by Shi Feng
This network shows the impact of papers produced by Shi Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Feng. The network helps show where Shi Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shi Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 19 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 61 | |
| 13 | 2018 | 21 | |
| 14 | 2017 | 62 | |
| 15 | 2017 | 14 | |
| 16 | 2017 | 2 | |
| 17 | 2015 | 1 | |
| 18 | 2014 | 12 | |
| 19 | 2013 | 1 | |
| 20 | 2011 | 3 |
About Shi Feng
Shi Feng is a scholar working on Transplantation, Nephrology and Cancer Research, having authored 63 papers that have together received 770 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (10 papers), Chronic Kidney Disease and Diabetes (8 papers), MicroRNA in disease regulation (6 papers), Renal Transplantation Outcomes and Treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Cancer-related molecular mechanisms research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Nephrology (136 citations), Hepatology (84 citations) and Transplantation (27 citations). Shi Feng has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Hong Jiang, Cuili Wang, Jianghua Chen, Xiujin Shen, Chunhua Weng, Xue Shao, Jianghua Chen, Yucheng Wang, Haitao Huang and Qi Ling. Their work appears in journals such as PLoS ONE, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.